Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Arena Pharmaceuticals, Inc.    ARNA

Delayed Quote. Delayed  - 08/26 10:00:00 pm
1.63 USD   --.--%
08/15 ARENA PHARMACEU : Announces Appointment of Vincent Aurentz as Chief ..
08/08 ARENA PHARMACEU : reports 2Q loss
08/08 ARENA PHARMACEU : Reports Second Quarter 2016 Financial Results and ..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector news 
Most relevant news about ARENA PHARMACEUTICALS, INC
08/15 ARENA PHARMACEUTICALS : Announces Appointment of Vincent Aurentz as Chief Busine..
08/08 ARENA PHARMACEUTICALS : reports 2Q loss
08/08 ARENA PHARMACEUTICALS : Reports Second Quarter 2016 Financial Results and Provid..
08/04 STOCKS WITHIN TRADERS RADAR : Community Health Systems, Inc. Arena Pharmaceutic..
08/01 ARENA PHARMACEUTICALS : to Release Second Quarter 2016 Financial Results and Pro..
07/27 ARENA PHARMACEUTICALS : Eisai Inc. and Arena Pharmaceuticals Announce FDA Approv..
07/19 EISAI : Inc. and Arena Pharmaceuticals Announce FDA Approval of BELVIQ XR® (lorc..
07/14 ARENA PHARMACEUTICALS : Eisai and Arena Pharmaceuticals Announce Regulatory Appr..
06/30 ARENA PHARMACEUTICALS : Announces Shift to Focus on Proprietary Clinical Stage P..
06/16 ARENA PHARMACEUTICALS : Announces Appointment of Kevin R. Lind as Chief Financia..
06/15 ARENA PHARMACEUTICALS : Announces Appointment of Kevin R. Lind as Chief Financia..
06/13 ARENA PHARMACEUTICALS : Announces USAN Approval of Nonproprietary Name "Etrasimo..
05/09 ARENA PHARMACEUTICALS : reports 1Q loss
05/09 ARENA PHARMACEUTICALS : Announces Appointment of Amit D. Munshi as President and..
05/09 ARENA PHARMACEUTICALS : Reports First Quarter 2016 Financial Results and Provide..
More most relevant news
All news about ARENA PHARMACEUTICALS, INC
08/25 ARENA PHARMACEUTICALS INC : Other Events (form 8-K)
08/18 ARENA PHARMACEUTICALS : Reports Second Quarter 2016 Financial Results and Provid..
08/15 ARENA PHARMACEUTICALS INC : Change in Directors or Principal Officers (form 8-K)
08/15 ARENA PHARMACEUTICALS : Announces Appointment of Vincent Aurentz as Chief Busine..
08/09 ARENA PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condit..
08/08 ARENA PHARMACEUTICALS : reports 2Q loss
08/08 ARENA PHARMACEUTICALS INC : Results of Operations and Financial Condition, Finan..
08/08 ARENA PHARMACEUTICALS : Reports Second Quarter 2016 Financial Results and Provid..
08/04 STOCKS WITHIN TRADERS RADAR : Community Health Systems, Inc. Arena Pharmaceutic..
08/01 ARENA PHARMACEUTICALS : to Release Second Quarter 2016 Financial Results and Pro..
More news
Sector news : Biotechnology & Medical Research - NEC
08/24DJAMGEN : FDA Rejects Amgen Hormonal-Imbalance Treatment
08/24DJAMGEN : FDA Rejects Amgen Hormonal-Imbalance Treatment
08/23DJPFIZER : to Acquire Key Drug -- WSJ
08/23DJDeal for Medivation Is the Latest In a Line of Similar Acquisitions -- WSJ
08/22DJPfizer's Medivation Deal Latest in Long Line of Similar Acquisitions
08/22DJPFIZER : to Acquire Medivation in Deal Worth $14 Billion -- 4th Update
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
08/26 ZAFGEN : Too Cheap To Ignore
08/10 ARENA : New Direction After $27 Million Loss?
08/08 Arena Pharmaceuticals' (ARNA) CEO Amit Munshi on Q2 2016 Results - Earnings C..
08/08 Arena Pharmaceuticals misses by $0.01, misses on revenue
08/07 Notable earnings after Monday?s close
07/21 The End Of Another Chapter In Obesity Drug Development


Advertisement
Financials ($)
Sales 2016 46,5 M
EBIT 2016 -76,7 M
Net income 2016 -85,8 M
Debt 2016 -
Yield 2016 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales 2016 8,52x
Capi. / Sales 2017 8,85x
Capitalization 397 M
More Financials
Chart ARENA PHARMACEUTICALS, INC
Duration : Period :
Arena Pharmaceuticals, Inc Technical Analysis Chart | ARNA | US0400471027 | 4-Traders
Full-screen chart
Technical analysis trends ARENA PHARMACEUTI...
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 6
Average target price 3,75 $
Spread / Average Target 130%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Amit D. Munshi President, Chief Executive Officer & Director
Craig M. Audet SVP-Operations & Head-Global Regulatory Affairs
Kevin R. Lind Chief Financial Officer & Executive Vice President
Dominic P. Behan Executive Director, Chief Scientific Officer & EVP
Donald D. Belcher Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ARENA PHARMACEUTICALS,..-14.21%397
INCYTE CORPORATION-25.27%15 236
CELLTRION, INC.--.--%11 367
LONZA GROUP AG14.78%10 130
QUINTILES TRANSNATIONA..10.24%8 968
ALKERMES PLC-43.94%6 744
More Results